<!DOCTYPE html>
<html lang="en">
 <head>
  <meta charset="utf-8">
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="stylesheet" type="text/css" href="/main.css">
  <link rel="icon" href="data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 100 100'%3E%3Cstyle%3E %23m %7B opacity:0; %7D%0A@media (prefers-color-scheme: dark) %7B %23m %7B opacity:1; %7D %23e %7B opacity:0 %7D%0A%7D %3C/style%3E%3Ctext id='m' y='.9em' font-size='90'%3EüèïÔ∏è%3C/text%3E%3Ctext id='e' y='.9em' font-size='90'%3Eüåû%3C/text%3E%3C/svg%3E">
  <title></title>
  <link rel="stylesheet" href="/style.css" type="text/css">
 </head>
 <body>
  <div id="page-wrapper">
   <div id="header" role="banner">
    <header class="banner">
     <img class="banner-logo" src="/images/soupault_logo.svg" alt="soupault logo">
     <div id="banner-text">
      <span class="banner-title">soupault</span>
            <span class="banner-subtitle">a static website management tool</span>
     </div>
    </header>
    <nav></nav>
   </div>
   <main>
    <h1>
     Morning Report 08/23/2021
    </h1>
    <p>
     Details modified, generalized, and otherwise fudged to be
HIPAA-compliant.
    </p>
    <h2>
     HPI
    </h2>
    <p>
     72F with chest pain, abdominal pain, and constipation.
    </p>
    <p>
     2-3mo weight loss, night sweats.
    </p>
    <p>
     2-3wk +perineal ?cyst, initially ttp and hurt to walk, but now
nontender.
    </p>
    <p>
     ~1wk constipation, BRB on TP.
    </p>
    <p>
     +crampy LLQ pain 8/10, x3-4 days, improves with positioning (supine
with head raised somewhat, 3-4 pillows).
    </p>
    <p>
     +LUQ and left-sided chest pain x1-2 days, radiates to L arm, not
related to exertion, lasts a few minutes.
    </p>
    <h2>
     OP Meds
    </h2>
    <ul>
     <li>
      duloxetine 60mg
     </li>
     <li>
      ASA 81mg
     </li>
     <li>
      melatonin 6mg
     </li>
     <li>
      no notable allergies
     </li>
    </ul>
    <h2>
     PMSHx
    </h2>
    <ul>
     <li>
      TVH-BSO for fibroids and endometriosis (~20y ago)
     </li>
     <li>
      hemorrhoids (no surgeries)
     </li>
     <li>
      s/p Moderna COVID vaccine (~4wk ago)
     </li>
     <li>
      UTD on mammograms, colonoscopies, no deviations from regular
schedule
     </li>
    </ul>
    <h2>
     SHx
    </h2>
    <ul>
     <li>
      monogamous x45y, G2P2 sons, 6yo grandson, all healthy
     </li>
     <li>
      never smoker
     </li>
     <li>
      social EtOH, none this year
     </li>
     <li>
      no non-Rx medicines
     </li>
     <li>
      previously secretary
     </li>
     <li>
      likes to DIY: painting, home crafts, gardening
     </li>
    </ul>
    <h2>
     FHx
    </h2>
    <ul>
     <li>
      M GM: uterine cancer (~40yo)
     </li>
     <li>
      P GF: lung ca, unknown type (~70yo)
     </li>
    </ul>
    <h2>
     PE
    </h2>
    <ul>
     <li>
      VS: wnl
     </li>
     <li>
      GEN: NAD
     </li>
     <li>
      HEENT: no LAD
     </li>
     <li>
      PULM: fine
     </li>
     <li>
      CV: fine
     </li>
     <li>
      ABD: NTND, +splenomegaly
     </li>
     <li>
      GYN: 0.5cm lesion R side of anterior perineum, NT, freely
mobile
     </li>
     <li>
      NEURO: fine
     </li>
    </ul>
    <h2>
     Labs
    </h2>
    <ul>
     <li>
      Hgb 12.7
     </li>
     <li>
      WBC 58.3
      <ul>
       <li>
        0 blasts
       </li>
       <li>
        0 atypical lymphs
       </li>
       <li>
        <ul>
         <li>
          slight L shift
         </li>
        </ul>
       </li>
      </ul>
     </li>
     <li>
      Plt 490
     </li>
     <li>
      BMP grossly wnl (gluc 202, <a href="https://www.ashclinicalnews.org/viewpoints/editors-corner/illegitimi-epic-non-carborundum-dont-let-epic-bastards-grind/">Cr
fine</a>)
     </li>
     <li>
      LFTs fine
     </li>
     <li>
      Trop &lt;0.01
     </li>
     <li>
      urate 10.4
     </li>
     <li>
      phos 5.0
     </li>
     <li>
      LDH 330
     </li>
     <li>
      fibrinogen 355
     </li>
    </ul>
    <h2>
     Other studies
    </h2>
    <ul>
     <li>
      EKG wnl
     </li>
     <li>
      CT-PE -ve
     </li>
     <li>
      CT a/p wwo
      <ul>
       <li>
        +10x7cm pelvic mass (central/R adnexum, exerting mass effect on
sigmoid colon)
       </li>
       <li>
        spleen ~20cm largest dimension w ?infarcts x2,
       </li>
       <li>
        L internal iliac vein filling defects c/w nonocclusive DVT
       </li>
      </ul>
     </li>
     <li>
      PET/CT
      <ul>
       <li>
        splenomegaly with diffusely increased uptake, diffuse FDG uptake of
axial and appendicular skeleton, mild uptake of abdominal pelvic lymph
nodes, and minimal to mild uptake in the pelvic mass.
       </li>
      </ul>
     </li>
    </ul>
    <h2>
     Further notes on hospital course
    </h2>
    <ul>
     <li>
      CEA 1.7 (wnl), CA-125 52 (-)
     </li>
     <li>
      urate 9.5 5d later w IVF, given rasburicase 3mg x1 -&gt; urate
3.8
     </li>
     <li>
      phos similarly without movement, sevelamer eventually helpful
     </li>
     <li>
      pelvic mass bx: smooth muscle
     </li>
     <li>
      BMBx: hypercellular &gt;90%, no blasts, +trilineage atypica &gt;
myeloid, MF-1 fibrosis.
     </li>
     <li>
      JAK2 -ve, BCR/ABL -ve
     </li>
     <li>
      NGS
      <ul>
       <li>
        BRAF 5% (MGUS, MM, hairy cell, hystiocytic/dendritic cell, solid
tumors, therapy-related myeloid neoplasms)
       </li>
       <li>
        KRAS 39% (MDS, AML, MDS/MPN inc CMML and JMML)
       </li>
       <li>
        BCOR 49% (?, possibly germline since allele fraction ~50%)
       </li>
       <li>
        BCORL1 48% (ditto)
       </li>
       <li>
        EZH2 93% (?, likely germline w loss of heterozygosity)
       </li>
      </ul>
     </li>
    </ul>
    <h2>
     And then‚Ä¶
    </h2>
    <p>
     Diagnosis is‚Ä¶ MDS/MPN/MF NOS.
    </p>
    <p>
     I.e., who knows.
    </p>
    <p>
     Started on hydroxyurea and decitabine, c/b recurrent bacteremia, so
currently tx on hold.
    </p>
    <hr>
    <h2>
     TLS
    </h2>
    <p>
     The big idea, and a few finer points.
    </p>
    <p>
     <a href="https://jamanetwork.com/journals/jamaoncology/fullarticle/2680750">![TLS](https://cdn.jamanetwork.com/ama/content_public/journal/oncology/937239/cpg180002fa.png?Expires=1632594426&amp;Signature=y4M-w5gXSYJCAVMqGVEyfaPaqZocE9nGaWFnmr7GY7vuiD35l7dL-yJLWn4l3huTo4yBhri1nM0KjQ4dZBBjEYH5tPmKExEJ0D6V~WNou9Av-OEwhyQh79y9feHp790YWY6hTKRJJge958meDu~OmNl8Sl0Wn1N4buZZgVNMRdRds9fKbaDr4DhEdCbMgFbbLSeW9h8KIOm49Gog8FREQNntRaN1jILZgKPBTr9sUNv2BUiapZaLPO4teIf33LkJXcStx6o1VVsZJoP-G-sfMKG3ql1O~23E6LFJeirnMt5MYQdfk-LZlieuSw16HzqTXr-jBtOicDtyFzDJ9VcQ~g__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA
=500x500 ‚ÄòJAMA Oncology 2018, TLS Review‚Äô)</a>
    </p>
    <h3>
     Cairo-Bishop classification system
    </h3>
    <p>
     (Most of the following derived from <a href="https://www.asn-online.org/education/distancelearning/curricula/onco/Chapter4.pdf">Chapter
4</a> of the American Society of Nephrology online <a href="https://www.asn-online.org/education/distancelearning/curricula/onco/">Onco-Nephrology
curriculum</a>, which is good and great.)
    </p>
    <h3>
     Laboratory TLS
    </h3>
    <p>
     Definition: Chemotherapy plus the two or more of the following within
3d before or 7d after initiation (so doesn‚Äôt account for the spontaneous
TLS seen in our patient).
    </p>
    <p>
     | Metabolite/Electrolyte | Criterion | | :‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äì |
:‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì: | | Uric Acid | &gt;=8 mg/dL or 25% increase from
baseline | | Potassium | &gt;=6mEq/L or 25% increase from baseline | |
Phosphorus | &gt;=4.5mg/dL or 25% increase from baseline | | Calcium |
25% <em>decrease</em> from baseline |
    </p>
    <p>
     The ‚Äú25% increase/decrease‚Äù part is contested, as it may not be
clinically meaningful if the value stays within the normal range.
    </p>
    <h3>
     Clinical TLS
    </h3>
    <p>
     | Laboratory TLS and one or more of | | :‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì‚Äì | |
creatinine &gt;= 1.5 ULN (Note: just use AKI criteria) | | cardiac
arrhythmia or sudden death | | seizure |
    </p>
    <ul>
     <li>
      risk assessment
     </li>
    </ul>
    <h3>
     Treating TLS
    </h3>
    <p>
     IVF, electrolytes, rasburicase.
    </p>
    <p>
     Rasburicase is the subject of a recent ‚ÄúThings We Do for No
Reason.‚Äù
    </p>
    <p>
     <a href="https://www.journalofhospitalmedicine.com/jhospmed/article/241443/hospital-medicine/things-we-do-no-reasontm-rasburicase-adult-patients-tumor">Pay-walled
article</a>, <a href="https://cdn.mdedge.com/files/s3fs-public/JHM01607424.PDF">PDF made
available by the authors</a>
    </p>
    <p>
     TL;DR: the evidence is thin, but could be reasonable to
    </p>
    <ul>
     <li>
      ppx w IVF and allopurinol for low-med risk,
     </li>
     <li>
      use single 3mg dose rasburicase as ppx in high-risk disease (don‚Äôt
use weight-based dosing),
     </li>
     <li>
      tx active TLS (laboratory or clinical) with aggressive fluid
resuscitation and electrolyte mgmt, possibly single 3mg dose.
     </li>
    </ul>
    <p>
     Hard outcomes in support of rasburicase are generally lacking, e.g.
consistently reducing renal injury, renal failure, length of stay.
    </p>
    <p>
     It also seems like the classification criteria need revamping, with a
larger N. It‚Äôs been a while. However, like redefining fever, it‚Äôs
difficult to get a clean slate, because we act on the established
criteria so aggressively.
    </p>
    <hr>
    <h2>
     MDS/MPN overlap syndromes
    </h2>
    <p>
     Not much to say here, except that the dx is not always clear-cut,
even with BMBx and NGS data, so the clinical picture matters, and
sometimes we have to shoot in the dark.
    </p>
    <hr>
    <p>
     Last updated: 2021-08-22
    </p>
   </main>
   <div id="footnotes"></div>
   <footer>
    <a href="/">home</a>
<a href="/about">about</a>
<a href="/now">now</a>
<a href="/posts">posts</a>
<a href="https://notes.beauhilton.com">notes</a>
<a href="https://talks.beauhilton.com">talks</a>
<a href="https://git.beauhilton.com">git</a>
<a href="/contact">contact</a>
<a href="/feed.xml">rss</a>
   </footer>
  </div>
 </body>
</html>
